C
Charter Research | Orlando, FL
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
ALZ-801
BOS-580
LY3154207
Mevidalen
Simufilam
ALZ- 801
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 5 total trials
This is a randomized, blinded, placebo-controlled study of BOS-580 in obese participants at risk for, or with biopsy-confirmed, nonalcoholic steatohe...
Enrolling
Nonalcoholic Steatohepatitis (NASH)
Drug: Placebo
Drug: BOS-580
The main purpose of this study is to look at how safe the study drug (mevidalen) is and whether it works to alleviate symptoms when given to people w...
Enrolling
Alzheimer Disease
Drug: Placebo
Drug: Mevidalen
This study is being conducted to evaluate the long-term safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 ge...
Invitation-only
Early Alzheimer's Disease
Drug: Experimental: ALZ-801
Trial sponsors
A
C
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems